Modus Advisors’s Compugen CGEN Stock Holding History

Modus Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28	Closed	-$43	–	137
2024 Q4	$43	Buy	+28	New	+$46	﹤0.01%	314
2021 Q3	–	Sell	-28	Closed	–	–	125
2021 Q2	$0	Buy	+28	New	+$227	﹤0.01%	255

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Modus Advisors's CGEN Position: Q1 2025 in Review

Modus Advisors sold out of Compugen (CGEN) in Q1 2025, closing a stake of 28 shares — an estimated $43 sold.

Modus Advisors first reported a position in CGEN in Q2 2021 and held it in 2 quarters. The position peaked at $43 in Q4 2024. 71 funds tracked by Wall St. Rank hold CGEN as of Q1 2025.

Modus Advisors reported no remaining Compugen position as of Q1 2025 after selling out during the quarter.
Modus Advisors sold 28 Compugen shares in Q1 2025, an estimated $43.
Modus Advisors first reported a position in Compugen in Q2 2021 and held it in 2 quarters.
Modus Advisors's Compugen position peaked at $43 in Q4 2024.
71 funds tracked by Wall St. Rank held Compugen as of Q1 2025.

Based on Modus Advisors's 13F filing for Q1 2025, filed 1 Apr 2025.